Patents by Inventor Kristian Rogers

Kristian Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REEL ASSEMBLY AND METHODS OF USE THEREOF
    Publication number: 20240132324
    Abstract: A reel system may receive a leading edge of a flexible buoyant pad. The flexible buoyant pad may have a use configuration having a first outer vertical envelope and a storage configuration having a second outer vertical envelope that is smaller than the first outer vertical envelope. The reel system may comprise at least one base member, an arm rotatably coupled to the base member and a rotatable axle coupled to the arm. The rotatable axle may be rotatable relative to the arm and the rotatable axle may adapted to receive the flexible buoyant pad and support the flexible buoyant pad in the storage configuration. Further, an actuatable input may supported by the arm. The actuatable input may be configured to rotate the rotatable axle relative to the arm.
    Type: Application
    Filed: September 21, 2023
    Publication date: April 25, 2024
    Applicant: Polaris Industries Inc.
    Inventors: Benoit Renaud, Erik Rogers, Kristian E. Nelson
  • Cytotoxicity mediation of cells evidencing surface expression of CD63
    Publication number: 20090155262
    Abstract: This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.
    Type: Application
    Filed: September 18, 2008
    Publication date: June 18, 2009
    Inventors: David S. F. Young, Helen P. Findlay, Susan E. Hahn, Luis A. G. da Cruz, Daad Sayegh, Kristian Rogers, Shankar Kumar, Paul Hinton
  • Cytotoxicity mediation of cells evidencing surface expression of CD63
    Patent number: 7442777
    Abstract: This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: October 28, 2008
    Assignee: Arius Research Inc.
    Inventors: David S. F. Young, Helen P. Findlay, Susan E. Hahn, Luis A. G. da Cruz, Daad Sayegh, Kristian Rogers, Shankar Kumar, Paul Hinton
  • Cytotoxicity mediation of cells evidencing surface expression of CD63
    Publication number: 20080044408
    Abstract: This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.
    Type: Application
    Filed: March 22, 2006
    Publication date: February 21, 2008
    Inventors: David Young, Helen Findlay, Susan Hahn, Luis da Cruz, Daad Sayegh, Kristian Rogers
  • Cytotoxicity mediation of cells evidencing surface expression of CD63
    Publication number: 20070025912
    Abstract: This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.
    Type: Application
    Filed: February 24, 2006
    Publication date: February 1, 2007
    Inventors: David Young, Helen Findlay, Susan Hahn, Luis da Cruz, Daad Sayegh, Kristian Rogers, Shankar Kumar, Paul Hinton
  • Cytotoxicity mediation of cells evidencing surface expression of CD63
    Publication number: 20060210474
    Abstract: This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.
    Type: Application
    Filed: March 3, 2006
    Publication date: September 21, 2006
    Inventors: David Young, Helen Findlay, Susan Hahn, Luis da Cruz, Daad Sayegh, Kristian Rogers